NCT04042714 2025-11-04
TAS-102 NEC
Baylor Research Institute
Phase 2 Terminated
Clinical Trials
10 trialsNCT05328908 2025-08-13
RELATIVITY-123
Bristol-Myers Squibb
Phase 3 Terminated
NCT04450836 2025-03-30
SOREGATT
UNICANCER
Phase 2 Terminated
NCT01904253 2024-09-05
A Phase 2 Study Comparing TAS-102 Versus Topotecan or Amrubicin to Treat Small Cell Lung Cancer Following Platinum-Based Chemotherapy
Taiho Oncology, Inc.
Phase 2 Terminated
NCT05223673 2024-08-20
COLSTAR
Servier
Phase 3 Terminated
NCT04073615 2024-05-02
A Study of Rivoceranib and Trifluridine/Tipiracil for Metastatic Colorectal Cancer (mCRC)
Elevar Therapeutics
Phase 1 Terminated
NCT04046887 2024-01-05
Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC)
Indiana University
Phase 1 Terminated
NCT04076761 2022-12-01
MOCHA
Sunnybrook Health Sciences Centre
Phase 2 Terminated
NCT02921737 2021-02-04
UF-STO-PANC-003
University of Florida
Phase 2 Terminated
NCT02654639 2018-08-07
ALEXANDRIA
Georgetown University
Phase 2 Terminated